NCT03367962View on ClinicalTrials.gov

Detection of Graft Versus Host Disease With [18F]F-AraG

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

June 21, 2023

Study Completion Date

October 21, 2023

Conditions
Graft Versus Host Disease
Interventions
DRUG

[18F]F-Ara-G

the \[18F\]F-AraG tracer will be administered as a single bolus injection of approximately 5 mCi into a hand or arm vein.

Trial Locations (1)

94305

Stanford Hospital, Stanford

Sponsors
All Listed Sponsors
collaborator

Stanford University

OTHER

lead

CellSight Technologies, Inc.

INDUSTRY